Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is looking at drug called trastuzumab emtansine alongside pertuzumab for breast cancer. The trial is for people whose breast cancer has a large number of HER2 receptors (it is HER2 positive).
Recruitment start: 31 January 2014
Recruitment end: 2 July 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Verrill
Roche
Last reviewed: 12 November 2015
CRUK internal database number: 11814
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
